Cormedix Inc (CRMD)
$3.56
Performance
- $3.51$3.73$3.56
1.4%
Downside
Day's Volatility :5.9%
Upside
4.56%
- $2.57$6.09$3.56
27.81%
Downside
52 Weeks Volatility :57.8%
Upside
41.54%
Returns
| Period | Cormedix Inc | |
|---|---|---|
3 Months | -8.72% | |
6 Months | -31.27% | |
1 Year | -10.78% | |
3 Years | -56.85% |
Highlights
Market Capitalization | 188.6M |
Book Value | $1.52 |
Dividend Share | 0.0 |
Dividend Yield | 4.3% |
Earnings Per Share (EPS) | -0.85 |
PEG Ratio | 0.0 |
Wall Street Target Price | 14.25 |
Profit Margin | 0.0% |
Operating Margin TTM | -140321.44% |
Return On Assets TTM | -33.94% |
Return On Equity TTM | -57.05% |
Revenue TTM | 29.7K |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -47.3% |
Gross Profit TTM | 61.7K |
EBITDA | -41.6M |
Diluted Eps TTM | -0.85 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.83 |
EPS Estimate Next Year | -0.73 |
EPS Estimate Current Quarter | -0.21 |
EPS Estimate Next Quarter | -0.23 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 300.28%
Technicals Summary
Sell
Neutral
Buy
Cormedix Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Cormedix Inc | 14.47% | -31.27% | -10.78% | -56.85% | -55.5% |
 Moderna, Inc. | 14.4% | -34.97% | -51.36% | -48.82% | 345.97% |
 Regeneron Pharmaceuticals, Inc. | 5.45% | 11.42% | 13.15% | 75.11% | 123.61% |
 Novo Nordisk A/s | -4.11% | 21.75% | 48.89% | 177.94% | 327.61% |
 Seagen, Inc. | 2.71% | 11.07% | 66.1% | 14.54% | 259.34% |
 Vertex Pharmaceuticals Incorporated | -7.59% | 2.8% | 11.45% | 56.2% | 102.13% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Cormedix Inc | NA | NA | 0.0 | -0.83 | -0.57 | -0.34 | 0.04 | 1.52 |
Moderna, Inc. | 24.73 | NA | 0.0 | -12.72 | -0.22 | -0.07 | 0.0 | 35.32 |
Regeneron Pharmaceuticals, Inc. | 23.18 | 23.18 | 1.75 | 42.5 | 0.17 | 0.09 | 0.01 | 234.47 |
Novo Nordisk A/s | 41.18 | 41.18 | 4.02 | 2.67 | 0.89 | 0.22 | 0.01 | 20.77 |
Seagen, Inc. | NA | NA | 18.53 | -4.16 | -0.28 | -0.13 | 0.03 | 13.52 |
Vertex Pharmaceuticals Incorporated | 26.38 | 26.38 | 0.5 | 15.04 | 0.23 | 0.14 | 0.0 | 64.05 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Cormedix Inc | Buy | $188.6M | -55.5% | NA | 0.0% |
Moderna, Inc. | Buy | $30.4B | 345.97% | 24.73 | -38.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $88.5B | 123.61% | 23.18 | 30.47% |
Novo Nordisk A/s | Buy | $459.0B | 327.61% | 41.18 | 35.11% |
Seagen, Inc. | Hold | $40.2B | 259.34% | NA | -32.61% |
Vertex Pharmaceuticals Incorporated | Buy | $90.5B | 102.13% | 26.38 | 35.94% |
Institutional Holdings
BlackRock Inc
5.76%Nomura Holdings Inc
5.38%Vanguard Group Inc
4.84%Elliott Investment Management L.P.
2.83%Geode Capital Management, LLC
1.97%Marshall Wace Asset Management Ltd
1.67%
Corporate Announcements
Cormedix Inc Earnings
Cormedix Inc’s price-to-earnings ratio stands at None
Read More
Company Information
cormedix inc. is a company based out of 745 route 202-206, suite 303, bridgewater, nj, united states.
Organization | Cormedix Inc |
Employees | 40 |
CEO | Dr. Matthew T. David M.D. |
Industry | Health Technology |
Discover More
Asymmetric Smart Alpha S&p 500 Etf
$3.56
-0.28%
Advisorshares Alpha Dna Equity Sentiment Etf
$3.56
-0.28%
Falcon's Beyond Global Inc
$3.56
-0.28%
Jaguar Global Growth Corporation I
$3.56
-0.28%
Missfresh Ltd
$3.56
-0.28%
Shuaa Partners Acquisition Corp I
$3.56
-0.28%
Rose Hill Acquisition Corp
$3.56
-0.28%
Partners Bancorp
$3.56
-0.28%
Bsquare Corp
$3.56
-0.28%